Meda Pharmaceuticals Inc. is the U.S. subsidiary of Meda AB.
The Meda Pharmaceutical product portfolio is focused primarily on respiratory, allergy, central nervous system, gastroenterology, musculoskeletal, rheumatology, erectile dysfunction, and women’s health products.
Latest News
October 15, 2012:
Acquisition of Women’s Health products completed »September 6, 2012:
Meda acquires Women’s Health products in the U.S. »
October 15, 2012:
Acquisition of Women’s Health products completed »September 6, 2012:
Meda acquires Women’s Health products in the U.S. »
Independent Education Grants
Meda Pharmaceuticals Inc. supports bona fide educational programs through the provision of educational grants.
Meda Pharmaceuticals Inc. supports bona fide educational programs through the provision of educational grants.